- Interstitial glucose readings are “older” than blood glucose readings by 5-15 minutes. This lag in time varies and can be longer after eating or after treating a low blood sugar. Therefore, CGM results don’t always match fingerstick blood glucose readings.
- A glucose sensor (small electrode) is inserted under the skin and measures interstitial glucose every 1-5 minutes. The readings are sent wirelessly to a device, either automatically or by manually scanning the sensor with a reader. There are two major types of CGM.
Types of CGM - iCGM and rtCGM
- An example of an intermittently viewed CGM (iCGM) also known as Flash Glucose Monitor (FGM) is Abbott’s Freestyle Libre. There is one product currently available in Canada under this category.
- The person with diabetes manually scans the iCGM sensor with a handheld reader to see current and stored results. iCGM has no transmitter piece.
- iCGM does not have automated alarms for when gluoce levels reach certain limits.
- Fingerstick testing is not needed for calibrations but is needed at other times.
- Real-time CGMs (rtCGM e.g. Dexcom and Medtronic) have a transmitter attached to the sensor to continuously send glucose results to a reading device.
- Dexcom sends results to a receiver or a smartphone app. Medtronic sends results to a Medtronic insulin pump.
- Recievers and apps can be programmed to alarm when glucose levels reach certain limits or change too quickly. Fingerstick testing is needed to calibrate rtCGMs at least twice daily and at other time
Benefits & Challenges (Brief)
Benefits of CGM may include:
- Improved glycemic control.
- Improved ability to identify glucose patterns and make daily management decisions.
- Less fingerstick glucose testing: The glucose readings from some CGM (Dexcom, Libre) are approved for use in calculating insulin doses so this can reduce fingerstick testing.
- More information than fingerstick tests:
- On The Device: CGM devices show a current glucose reading, a graph of previous hours’ glucose levels and rate of change (ROC) arrows. More information can lead to different decisions. E.g. A reading of 5.2 mmol/L ↓↓ (dropping quickly) would likely require action to prevent a low, whereas a 5.2 mmol/L → (stable) might not.
- In Reports: CGM devices offer various reports, including some type of Ambulatory Glucose Profile (AGP). The AGP translates glucose data into an image to easily identify glucose patterns. The "Dark Blue River" in the AGP below represents 50% of all readings. The "Light Blue River" (between the top and bottom edges of the light blue) contains 80%. A "flatter" and "narrower" river represents more desirable glycemic control.
Challenges of CGM include:
- Alarm fatigue, feeling overwhelmed by data (this could lead to too many insulin adjustments)
- Unrealistic expectations
- Skin irritation
- The requirement for fingerstick glucose tests for some situations (all brands).
- Lag time: Sensor glucose (SG) readings can lag behind blood glucose (BG) readings at times, particularly when glucose levels change quickly (after eating, bolusing, treating low blood sugars, exercise).
Brand Information (Brief)
- Abbott’s Libre
- 2020 sensor wear time is 2 weeks. Requires smart phone app (free) or reader (separate purchase). No transmitter is required.
- Read a Libre summary on our CGM Brand Information page.
- Dexcom G6
- 2020 sensor wear time is 10 days. A separate transmitter is required and lasts 100-112 days. Requires a smart phone app (free) or stand-alone receiver (separate purchase).
- Read a Dexcom summary on our CGM Brand Information page.
- Medtronic Guardian Connect CGM
- 2020 sensor wear time is 7 days. A separate rechargable transmitter is required and lasts a year or longer. A free smart phone app is required
- Read a Medtronic CGM summary on our CGM Brand Information page.
For a list of all our CGM webpages, please visit Glucose Sensors and Continuous Glucose Monitors (CGM).